Company intelligence / Profile preview

Morgancreek Investment Holdings

Chapel Hill, North Carolina, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Morgan Creek Capital Management is an alternative investment management firm that provides asset management services to institutional and qualifying individual clients. The firm maintains a significant presence in the life sciences sector through its dedicated Life Sciences team and a strategic partnership with Exome Asset Management. Morgan Creek focuses on investing in innovative healthcare companies across various stages, with a particular emphasis on gene therapy, oncology, and rare diseases. Their life sciences strategy aims to capitalize on the rapid pace of innovation in biotechnology and medical technology globally.

Therapeutic areas: OncologyRare Diseases
Industry: Investors

Partnerships

Exome Asset Management

Beyond the preview

Go deeper on Morgancreek Investment Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Morgancreek Investment Holdings.

Explore the full profile